Covaxin Efficacy - Search Videos

Bharat Biotech's Covaxin efficacy rate observed at 77.6% in phase-3clinical trials. @Runjhunsharmas shares more details. | News18

Bharat Biotech's Covaxin efficacy rate observed at 77.6% in phase-3clinical trials. @Runjhunsharmas shares more details. | News18

21.5K viewsJun 22, 2021

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

Hindustan TimesMohammad Shuaib

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Hindustan TimesMohammad Shuaib

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief

Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief

NDTVRishika Baruah

Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet

#Covaxin shows vaccine efficacy of 81% in phase 3 trial. What does the vaccine efficacy number mean? Here's everything you need to know! | News18

1.1K viewsMar 4, 2021

Covaxin phase 3 data shows 77.8 percent efficacy against Covid-19 symptoms

timesnownews.comTimesNow

Concerns over Covaxin efficacy result in low turnout for COVID vaccination

timesnownews.com

Covaxin trial data: Bharat Biotech vaccine shows 77.8% overall efficacy, 65% against Delta variant | https://bit.ly/3xgR2mz | The Economic Times

19.1K viewsJul 3, 2021

FacebookThe Economic Times

#BharatBiotech releases phase 3 trial data for #Covaxin. '65.2% efficacy against the #Delta variant of #Coronavirus.' Listen in to reactions. | TIMES NOW

15.5K viewsJul 3, 2021

FacebookTIMES NOW

Covaxin Vaccine FAQ: All That You Need To Know About This Vaccine

onlymyhealth.com

'Coincidence that PM Modi received Covaxin': Owaisi raises questions over Covishield's efficacy

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial

Big boost to India's Covid vaccination drive: Covaxin shows 81% interim efficacy

India TodayIndia Today Television

Covaxin, the homegrown coronavirus vaccine that was authorised for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its Phase 2 results. Medical journal Lancet has said that efficacy cannot be determined by Phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic". The Lancet report says the results reported in the study of Phase 2 results do not permit efficacy assess

27.9K viewsMar 9, 2021

Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing |

Covaxin will prove to be better against new strain of Covid-19: ICMR chief Balram Bhargava

India TodayIndia Today Television

Reality Check: The Covaxin Controversy

NDTVSreenivasan Jain

Bharat Biotech announces phase 3 results of Covaxin, says it demonstrates interim clinical efficacy of 81%

Dr Randeep Guleria, Director, AIIMS says Covaxin efficacy data is encouraging but trails will continue. This is an interim Phase 3 result based on 43 infections, but for final results, 130 infections need to be studied. But Dr Guleria says this will go a long way in promoting the vaccine program in the country. | NDTV

17.7K viewsMar 3, 2021

Experts question Covaxin's efficacy, Covaxin still in phase 3 trial. #FirstUp | India Today

1.9K viewsJan 4, 2021

FacebookIndia Today

Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official |

Covaxin or Covishield, Which Vaccine is Better to Take? Know from Dr. MS Kanwar

onlymyhealth.com

Watch: Covaxin meets WHO standards of protection

India TodayIndia Today Television

Covaxin 100% effective against severe COVID cases: ICMR

Phase 3 Trial in US Shows India's Covaxin is 100% Effective Against Severe Covid-19

Bharat Biotech's Covaxin effective against new COVID-19 variants, reveals study

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute

See more